<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00701064</url>
  </required_header>
  <id_info>
    <org_study_id>MHBA-008-08S</org_study_id>
    <nct_id>NCT00701064</nct_id>
  </id_info>
  <brief_title>Bright Light: An Adjunct Treatment for Combat Posttraumatic Stress Disorder (PTSD)</brief_title>
  <official_title>Bright Light: An Adjunct Treatment for Combat PTSD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Arizona State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are testing novel treatments for combat PTSD: bright light exposure and
      negation ion exposure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Seventy Operation Iraqi Freedom (OIF)/Operation Enduring Freedom (OEF) Veterans with
      posttraumatic stress disorders (PTSD) will be randomly assigned to one of two 4-week
      treatments (45 min/day): (1) bright light exposure or (2) a negative ion generator. Clinical
      assessments ,as well as self-reported measures of PTSD, anxiety, depression, and sleep will
      be assessed
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2009</start_date>
  <completion_date type="Actual">September 2, 2019</completion_date>
  <primary_completion_date type="Actual">November 21, 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Assessed PTSD Scale (CAPS-2)</measure>
    <time_frame>Mean change from baseline to post-treatment (5-6 weeks later)</time_frame>
    <description>The CAPS-2 is administered by a trained clinician. It is designed to assess changes in PTSD severity over time, the scale ranges from 0-136. Higher levels indicate greater severity of PTSD.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Global Impressions Scale (CGI)</measure>
    <time_frame>Baseline severity to post-treatment (4 weeks later) Change</time_frame>
    <description>The CGI assesses baseline severity on a 7-point scale, and change on 7-point scale. (1=normal; 4=moderately ill; 7= among the most severely ill). Change: 1=very much improved, 2=much improved, 3=minimally improved, 4=no change, 5=minimally worse, 6=much worse, 7=very much worse</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Posttraumatic Stress Disorder Checklist (PCL-M)</measure>
    <time_frame>Baseline to following 4-week treatment</time_frame>
    <description>Self-rated PTSD scale with 17 items (rated 1-5) with range of 17-85. Higher score = worse severity of PTSD. Reported are decreases from baseline to end-of-study.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">71</enrollment>
  <condition>Posttraumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>Bright Light Exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bright Light (30 min/day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Negative Ion Generator</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Negative Ion Generator (30 min/day)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bright Light Exposure</intervention_name>
    <description>Administered via bright light box</description>
    <arm_group_label>Bright Light Exposure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Negative Ion Generator</intervention_name>
    <description>Administered via Negative Ion Generatore</description>
    <arm_group_label>Negative Ion Generator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Veteran of Operation Iraqi Freedom or Operation Enduring Freedom with Posttraumatic
             Stress Disorder

          -  receiving other treatment or stopped other treatment prior to study

        Exclusion Criteria:

          -  bipolar disorder

          -  psychosis

          -  alcohol/drug abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shawn D. Youngstedt, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC</name>
      <address>
        <city>Columbia</city>
        <state>Arizona</state>
        <zip>29209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>June 17, 2008</study_first_submitted>
  <study_first_submitted_qc>June 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2008</study_first_posted>
  <results_first_submitted>March 26, 2015</results_first_submitted>
  <results_first_submitted_qc>April 8, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 29, 2015</results_first_posted>
  <last_update_submitted>September 11, 2019</last_update_submitted>
  <last_update_submitted_qc>September 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>posttraumatic stress disorder</keyword>
  <keyword>phototherapy</keyword>
  <keyword>anxiety</keyword>
  <keyword>depression</keyword>
  <keyword>sleep</keyword>
  <keyword>negative ion generator</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Bright Light Exposure</title>
          <description>Bright Light (30 min/day)
Bright Light Exposure: Administered via bright light box</description>
        </group>
        <group group_id="P2">
          <title>Negative Ion Generator</title>
          <description>Negative Ion Generator (30 min/day)
Negative Ion Generator: Administered via Negative Ion Generatore</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>initiated other PTSD treatment</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Veterans with PTSD</population>
      <group_list>
        <group group_id="B1">
          <title>Bright Light Exposure</title>
          <description>Bright Light (30 min/day)
Bright Light Exposure: Administered via bright light box</description>
        </group>
        <group group_id="B2">
          <title>Negative Ion Generator</title>
          <description>Negative Ion Generator (30 min/day)
Negative Ion Generator: Administered via Negative Ion Generatore</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="35"/>
            <count group_id="B2" value="36"/>
            <count group_id="B3" value="71"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37.5" spread="9.3"/>
                    <measurement group_id="B2" value="36.0" spread="8.0"/>
                    <measurement group_id="B3" value="36.7" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="32"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Clinician Administered PTSD Scale (CAPS2)</title>
          <description>PTSD assessed by a skilled clinician, the CAPS2 is the most common clinical and experimental measure of PTSD severity. It is designed to assess changes in PTSD severity over time, the scale ranges from 0-136. Higher levels indicate greater severity of PTSD. Scores of 30 or more or 40 or more have been considered indicated of moderate severity PTSD.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.0" spread="20.2"/>
                    <measurement group_id="B2" value="62.3" spread="26.6"/>
                    <measurement group_id="B3" value="62.6" spread="23.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Clinical Global Impression Scale (CGI)</title>
          <description>Clinical judgement of the severity of one's condition at baseline (7 point scale: 1=normal; 4=moderately ill; 7= among the most severely ill)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.3" spread="0.9"/>
                    <measurement group_id="B2" value="4.2" spread="1.6"/>
                    <measurement group_id="B3" value="4.3" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>PTSD Checklist (PCL)</title>
          <description>A 17-item self-rated PTSD scale ranging from 17-105, with higher levels indicating more severe PTSD. The PCL correlates highly with the CAPS-2.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.3" spread="10.1"/>
                    <measurement group_id="B2" value="47.2" spread="15.2"/>
                    <measurement group_id="B3" value="46.3" spread="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pittsburgh Sleep Quality Inventory</title>
          <description>A common instrument that assesses sleep quality over the previous month. The PSQI range is 0-21 with higher scores indicating worse sleep. Scores of &gt; 5 have been considered indicative of a sleep problem.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.3" spread="3.4"/>
                    <measurement group_id="B2" value="10.4" spread="4.2"/>
                    <measurement group_id="B3" value="10.4" spread="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Clinical Assessed PTSD Scale (CAPS-2)</title>
        <description>The CAPS-2 is administered by a trained clinician. It is designed to assess changes in PTSD severity over time, the scale ranges from 0-136. Higher levels indicate greater severity of PTSD.</description>
        <time_frame>Mean change from baseline to post-treatment (5-6 weeks later)</time_frame>
        <population>Separate analysis will be conducted to include drop-outs and exclusions. reported are end of study data</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Bright Light</title>
            <description>Bright Light (30 min/day)
Bright Light Exposure: Administered via bright light box</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Placebo Negative Ion Generator</title>
            <description>Negative Ion Generator (30 min/day)
Inactivated Negative Ion Generator: Administered via Negative Ion Generator</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Assessed PTSD Scale (CAPS-2)</title>
          <description>The CAPS-2 is administered by a trained clinician. It is designed to assess changes in PTSD severity over time, the scale ranges from 0-136. Higher levels indicate greater severity of PTSD.</description>
          <population>Separate analysis will be conducted to include drop-outs and exclusions. reported are end of study data</population>
          <units>change in units on scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.10" spread="18.63"/>
                    <measurement group_id="O2" value="8.84" spread="17.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Clinical Global Impressions Scale (CGI)</title>
        <description>The CGI assesses baseline severity on a 7-point scale, and change on 7-point scale. (1=normal; 4=moderately ill; 7= among the most severely ill). Change: 1=very much improved, 2=much improved, 3=minimally improved, 4=no change, 5=minimally worse, 6=much worse, 7=very much worse</description>
        <time_frame>Baseline severity to post-treatment (4 weeks later) Change</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Bright Light</title>
            <description>Bright Light (30 min/day)
Bright Light Exposure: Administered via bright light box</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Placebo Negative Ion Generator</title>
            <description>Negative Ion Generator (30 min/day)
Inactivated Negative Ion Generator: Administered via Negative Ion Generator</description>
          </group>
        </group_list>
        <measure>
          <title>Clinical Global Impressions Scale (CGI)</title>
          <description>The CGI assesses baseline severity on a 7-point scale, and change on 7-point scale. (1=normal; 4=moderately ill; 7= among the most severely ill). Change: 1=very much improved, 2=much improved, 3=minimally improved, 4=no change, 5=minimally worse, 6=much worse, 7=very much worse</description>
          <units>units on scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.61" spread="0.18"/>
                    <measurement group_id="O2" value="3.16" spread="0.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Posttraumatic Stress Disorder Checklist (PCL-M)</title>
        <description>Self-rated PTSD scale with 17 items (rated 1-5) with range of 17-85. Higher score = worse severity of PTSD. Reported are decreases from baseline to end-of-study.</description>
        <time_frame>Baseline to following 4-week treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: Bright Light</title>
            <description>Bright Light (30 min/day)
Bright Light Exposure: Administered via bright light box</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: Placebo Negative Ion Generator</title>
            <description>Negative Ion Generator (30 min/day)
Inactivated Negative Ion Generator: Administered via Negative Ion Generator</description>
          </group>
        </group_list>
        <measure>
          <title>Posttraumatic Stress Disorder Checklist (PCL-M)</title>
          <description>Self-rated PTSD scale with 17 items (rated 1-5) with range of 17-85. Higher score = worse severity of PTSD. Reported are decreases from baseline to end-of-study.</description>
          <units>decrease in units on scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.03" spread="1.93"/>
                    <measurement group_id="O2" value="6.25" spread="1.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>At the end of baseline period and weekly during the 4-week intervention, we monitored the subjects for suicidal thoughts with the Beck Suicide Scale.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Arm 1: Bright Light Exposure</title>
          <description>Bright Light (30 min/day)
Bright Light Exposure: Administered via bright light box</description>
        </group>
        <group group_id="E2">
          <title>Arm 2: Negative Ion Generator</title>
          <description>Negative Ion Generator (30 min/day)
Negative Ion Generator: Administered via Negative Ion Generatore</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="32"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Shawn Youngstedt</name_or_title>
      <organization>VA</organization>
      <phone>803-767-3208</phone>
      <email>shawn.youngstedt@asu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

